Oculis Holding AG
OCS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001953530
No open-market purchases or sales by Oculis Holding AG insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $322.0M in total; no superinvestor holds it.
Other share classesOCSAW
Q3 2025 vs. Q2 2025
How the institutions holding Oculis Holding AG changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 23 | 20 | −3 |
| Shares | 5.11M | 10.9M | +5.79M (+113.4%) |
| Value | $99.1M | $191.7M | +$92.6M (+93.5%) |
New holders (4)
Institutions that held Oculis Holding AG at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| EQT Fund Management S.a r.l. | 5,900,294 | $103.7M | 5.57% |
| Aventura Private Wealth, LLC | 4,000 | $70.3K | 0.03% |
| China Universal Asset Management Co., Ltd. | 1,000 | $17.6K | 0.00% |
| Wolverine Asset Management LLC | 269 | $4.73K | 0.00% |
Sold out (7)
Institutions that held Oculis Holding AG at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Marshall Wace, LLP | 20,253 | $393.1K |
| Polen Capital Management LLC | 19,472 | $378.0K |
| Options Solutions, LLC | 19,472 | $378.0K |
| Kestra Private Wealth Services, LLC | 15,236 | $295.7K |
| Bellevue Group AG | 9,700 | $188.3K |
| Royal Bank of Canada | 45 | $1.00K |
| Raymond James Financial Inc | 26 | $505 |